25+ years biotech experience
Led ChemGenex to $231M acquisition
Chair of Avecho Biotechnology and Tessara Therapeutics
25+ years biotech experience
Chair of Prescient Therapeutics and AusBiotech
Negotiated and closed >$50M in partnering deals
Professor of Medical Biology, Deakin University
20+ years pioneering MEF2 research
$MM in competitive grants
40+ years cancer research and medicinal chemistry
Founding Partner SYNthesis BioVentures
Multiple successful exits
Biotech patent specialist
20+ years with Australian biotech companies
Former Chief Medical Officer, CSL Ltd (ASX:CSL)
25+ years global clinical development, governance and regulatory leadership
Experienced Chair and Director of public and private companies
Founder and former CEO, Opthea Ltd (ASX/Nasdaq)
25+ years in biotechnology, oncology and ophthalmic drug development
Secured >AU$830M in capital; led Phase 3 global clinical trials